Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — As Security Concerns Escalate, B.C. Alters Law on Cannabis Shop Window Coverings

Last Friday night, all across Vancouver, British Columbia, cannabis retail shops were taking the coverings off of their windows. This was after the government altered the law in response to a spike in cannabis store robberies in the province. The move is meant to protect both customers and sellers.

Until recently, the opaque film window coverings were a condition of cannabis retail shop provincial licensing, ensuring that none of the goods were visible from the outside; the approach was an attempt to keep minors away from cannabis products. While some stores have roomy interiors or stylish furnishings that deftly cover the material, those can be pricey solutions; hence, the majority of stores choose to use frosted windows.

The window covering option has creates risks for personnel and customers who are inside because visibility and situational awareness are greatly reduced; the installation of surveillance cameras by many stores hasn’t helped. This caused marijuana sellers to convey their safety worries to the government.

“I know that legalizing marijuana is a big issue, but our safety and the safety of our customers shouldn’t be in jeopardy,” stated Up in Smoke’s Matthew Greenwood.

Security footage from Kingsway Cannabis showed an attempted armed robbery in March. The 20-second video, which depicts a man breaking into the store just after 8 p.m., was shared on Twitter by the proprietor of Kingsway Cannabis. Although nobody was hurt and the would-be thief fled empty-handed, the video brought to light a safety issue because the opaque windows cut off personnel from passersby who might have called for aid.

In the same month, the staff of Nanaimo’s Mood Marijuana was horrified twice in a row when a man stole valuable merchandise on consecutive evenings. The business took its window covers down after the second incident.

The Marijuana Council of Canada has been begging for a revision of the visibility rule on the grounds that the storefronts appear uninviting to customers as well as secluded and vulnerable to theft, creating dangerous working conditions for staff. The group is glad that the safety issues raised by its members, as well as the negative perception the window screens gave to business owners, were taken into account. The council maintained that cannabis goods are no different from those offered in alcohol shops.

Although merchants are still unsure about a few aspects of the altered law, which still forbids window displays of cannabis items, the majority are optimistic that specifics can be worked out with inspectors.

With security concerns rising in most jurisdictions where marijuana sales are legal, many companies such as Advanced Container Technologies Inc. (OTC: ACTX) will be following how the authorities respond to contain the threats these businesses face. This is because what happens to marijuana companies can have a domino-effect on other industries that are interlinked with the marijuana space.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Bright Green Corporation (NASDAQ: BGXX) Announces Pricing of $3.5M Private Placement

Bright Green (NASDAQ: BGXX) is one of the few companies selected by the U.S. government to grow, manufacture and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. The company recently announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 3,684,210 shares of common stock and warrants to purchase up to 3,684,210 shares of common stock, at a purchase price of $0.95 per share and accompanying warrant. Bright Green expects approximately $3.5 million in gross proceeds from the private placement. EF Hutton, division of Benchmark Investments LLC, is acting as the exclusive placement agent for the offering.

To view the full press release, visit https://cnw.fm/KQLQV

About Bright Green Corporation

Bright Green is one of the very few companies authorized by the U.S. government to grow, manufacture and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. Bright Green’s registration by the U.S. Drug Enforcement Administration gives it the opportunity to advance its vision of improving quality of life through the opportunities presented by cannabis-derived therapies. To learn more, visit www.BrightGreen.us.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The Green Label Expo: Las Vegas 2023 Edition

The Green Label Expo 2023 edition will be held at the World Market Center in Las Vegas on the 13th & 14th of September, welcoming thousands of CBD experts, alternative product professionals, counterculture experts, and business owners to discover a vast array of global suppliers in trending sectors such as beauty, health & wellness, pet products, foods, business services, and more. As the need for embracing alternative products surges, the vibrant city of Las Vegas is set to welcome the largest trade show for CBD and alternative product professionals. This two-day event will feature an extensive showcase of innovative products/services, industry leaders, and live entertainment bringing the industry closer together while catering to the growing demand for alternative options.

The Green Label Expo will feature thought-provoking seminars and interactive networking sessions throughout the show floor. An impressive lineup of keynote speakers will share the industry trends, latest innovations, and best practices to excel in the fast-growing emerging industries including CBD, psychedelics, and cannabis. This dynamic event aims to inspire participants to embrace alternative products and provide education on how to make a positive impact on society.

By bringing together businesses and individuals, the expo will empower attendees to make informed decisions, gain industry insights and expert consultations from leaders in areas such as payment solutions, financial services, logistics, marketing, compliance and more. The only event in Las Vegas designed specifically for CBD professionals and alternative product suppliers and buyers, this is the business event not to be missed.

The #1 Destination for Alternative Product Suppliers and Buyers

Supported by industry experts, the educational program provides opportunities to learn valuable insights into topics such as sourcing products, growing revenue, regulatory & compliance guidance, and more. This premier event will enable participants to meet industry leaders, learn advanced skills, and implement them in their upcoming projects.

Focused on connecting the industry, The Green Label Expo offers a perfect platform to forge new connections, consult with industry experts and learn best practices. It will also serve as a marketplace for potential buyers to gain a competitive edge. Reserve your free ticket today and bring a friend to discover the latest in the emerging world of alternative products.

To learn more, please visit https://cnw.fm/6GNLE.

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Shareholders Approve Board Appointments Amid Push for Diversity; Vote to Endorse 6 Agenda Items in 2023 Annual Shareholder Meeting

Lexaria held its virtual 2023 Annual Shareholders meeting on May 9, 2023
On the agenda were the election of six director nominees, the ratification of the appointment of the company’s independent registered public accounting firm, and the approval of a one-time repricing of specific issued stock options, among others
All items presented received approval, with the highest approval percentage standing at 97.6% and the lowest at 63.1%
The meeting presented an opportunity for Lexaria to evaluate areas of expertise that would provide additional benefits to the company and its shareholders while also adding diversity to its board

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, on May 9 held its 2023 Annual Shareholder Meeting, in which 3,372,024 shares, constituting 56.3% of the company’s issued share capital, were represented.

Carrying on with the theme of the previous year’s Annual Meeting, the virtual 2023 Annual Shareholder Meeting adhered to COVID-19 protocols, with provisions for shareholders to vote via proxy. Among the meeting’s agenda items included the election of Chris Bunka, John Docherty, Nicholas Baxter, Ted McKechnie, Albert Reese Jr., and Dr. Catherine Turkel as directors. Shareholders also voted on the appointment of Malone Bailey LLP as auditors, the approval of the stock option pricing, and the approval of the amendment to the maxim number of shares issuable according to the incentive Equity Plan (https://cnw.fm/T5kov).

All items put to the vote were selected in favor of, with the highest approval percentage standing at 97.6% for the election of Dr. Catherine Turkel as director and the lowest standing at 63.1% for the approval of the addition of an evergreen formula to the Incentive Equity Plan. Percentages were calculated based on abstained votes being counted as a vote against the resolution.

Lexaria and its management expressed their support of recent initiatives the SEC and the Nasdaq Group took to encourage diversity within the board of directors of reporting companies. With the company reviewing its board composition annually, this meeting presented an opportunity to not only evaluate areas of expertise that would provide additional benefits to the company and its shareholders but also add to the diversity of its board. Lexaria hopes that with these appointments, it will further pursue its goal of leveraging technology in pharmaceutical applications. More so, it looks to make its patented DehydraTECH(TM) technology and offerings even more accessible to the masses (https://cnw.fm/LbIuk).

For more details, please visit Lexaria’s proxy statement filed with the Securities Exchange Commission via Edgar and with the BC Securities Commission and Ontario Securities Commission via SEDAR on March 22, 2023.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — NIDA Director Wants Cannabis Products Federally Regulated

According to a senior federal health official, cannabis products must be controlled as states continue to legalize marijuana. Nora Volkow, director of NIDA, stated that while it would be ideal if states took their time enacting reform, the reality is that they are enacting reform and people need to know what they can do to lessen negative impacts. Volkow asserted that it is crucial to regulate the sale of products and inform the public about potential negative consequences.

The official’s remarks are noteworthy because, although she did not specifically demand federal reform, such a shift in policy would be required to impose controls on interstate marijuana sales on a national level.

Volkow also acknowledged new studies looking into a potential connection between marijuana usage and an increased risk of psychosis, noting that regrettably, cannabis may not be as innocuous as it appears. Although Volkow cautioned against the potential risk of heavy use of marijuana products with high potency, she stated in 2021 that she hasn’t yet seen proof that occasional marijuana usage by adults is detrimental.

When it comes to regulations, Congress has sponsored multiple legalization measures in recent sessions, but none of those bills have been passed. The end result has been a hodgepodge of state-level regulatory frameworks.

This month, Volkow stated before a senate committee that there is growing evidence that psychedelics have a major potential as treatments for some mental health issues and that this is a subject of tremendous interest for academics. In recent years, the director has also turned into a strong opponent of drug criminalization generally, pointing out racial inequalities in enforcement and the futility of addressing addiction as a criminal rather than a public health issue.

According to Volkow, the criminalization of drugs has led to a systemically racist society where Blacks are regarded differently from other groups. Additionally, she discussed the link between drug criminalization and racial prejudice in 2021, stating that the United States is now dealing with a long history of discriminatory and racist laws, many of which are still in place today.

In a blog post from last year, Volkow stated that there is a pressing need to rethink addiction therapy, particularly by allocating more funds to diagnosing pre-addiction to enable patients to receive care before the condition.

Given the concerns being expressed about the high potency of the marijuana that is currently available, companies seeking to avail standardized medicines from cannabis, such as IGC Pharma Inc. (NYSE American: IGC), deserve to be applauded because those formulations, once approved, can offer users a safe way to benefit from cannabis compounds without exposing themselves to any potential risks associated with consuming high-potency marijuana while addressing their medical needs.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Maryland Governor Enacts Bill Offering Parental Protections for Using Medical Marijuana

Maryland Governor Wes Moore has signed a bill offering protections for parents and guardians who use medical marijuana. The bill prevents state officials from classifying parents who use medical marijuana for allowed conditions as being “neglectful” of their children.

After Maryland voters voted in favor of a ballot measure to legalize medical cannabis last year, state lawmakers passed regulations for the commercial market, which were signed into law by the governor. The new bill protecting parents will take effect on July 1, 2023, the same day Maryland’s medical marijuana market will launch and begin legal sales.

The measures to protect parents who participate in the medical marijuana market were passed by Maryland lawmakers last month in anticipation of the market’s official launch. According to the bill’s language, child neglect in Maryland will not include the use of marijuana by any individual or parent with temporary or permanent responsibility for the supervision of a child.

However, the bill provided certain exceptions, including cannabis use among parents and guardians being classified as neglect. This includes if the parent’s or guardian’s cannabis use harms the child’s health or welfare or places the child at significant risk of harm. The bill also allows adults aged 21 years and older to purchase and possess up to 1.5 ounces of cannabis and grow a pair of plants for personal use.

Maryland joins the dozens of states that now allow their residents to use medical marijuana if they suffer from one of several specified conditions. However, since marijuana is still illegal at the federal level, users can find themselves facing legal repercussions despite using cannabis in adherence with state law. States with legal markets have worked around this by providing legal users with protections that prevent them from being punished for using medical cannabis legally.

For example, in California, Governor Gavin Newsom signed a bill that would require social workers on call for child welfare to handle marijuana use by parents the same way they deal with alcohol. Assemblyman Reggie Jones-Sawyer, who sponsored the legislation, stated in a summary that marijuana use by itself shouldn’t be a basis for intervention into family life. He noted that just as with prescription medication and alcohol, guardians and parents should be able to legally and safely consume cannabis without fear of losing custody of their children as long as they aren’t putting the child’s safety and health at risk.

In Maryland, lawmakers recently moved to increase protections for cannabis users by approving a measure to prevent police from using the smell of cannabis as a basis for vehicle searches.

The additional reforms that the lawmakers in Maryland are making will further ease the environment within which cannabis users and companies operate, and this improvement could come with benefits for many companies connected with the cannabis space, including entities such as Advanced Container Technologies Inc. (OTC: ACTX) whose interest is in providing cultivation equipment geared at enabling the optimization of indoor cannabis cultivation.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Jaxx Cannabis Owner, Veteran and Cannabis Advocate Featured in Recent Episode of The Plant Lady

Female empowerer and owner of Jaxx Cannabis, JM Balbuena, was featured in a recent episode of The Plant Lady podcast. JM joined host Jackie Bryant to discuss her wellness brand and dispensary’s humble beginnings in San Diego county, which wanted to scrub cannabis culture from its image, to the company’s success, which JM attributes much to patience and working for the system instead of against it. During the program, the host and guest “reminisce about the low-key dispensaries scattered around every neighborhood and the elaborate rouses needed as a front to keep them open like under-stocked coffee shops or deserted medical clinics. It’s not that these shops were selling illegal drugs, but that there weren’t enough licenses allowing businesses to sell weed in the cities. When supply meets demand and opportunity strikes, hundreds of dispensaries found ways to continue operation,” reads a recent article discussing the interview. JM goes on to describe her successes in owning a small business like Jaxx and advocating for social equity amongst the cannabis industry—as well as in the San Diego communities where her brand stood. This connected her with the residents of Ramona, Mount Hope and La Mesa who chose her over a larger company. Now, Jaxx Cannabis and JM are working with the Mount Hope Community Alliance Program to restore a park in the area to signify it as a landmark of San Diego. The local Jaxx brand helps fund social projects that will, in turn, uplift the collective population. “The culture is compassion and community. Those two things are the pillars of cannabis,” JM says during the episode. “You can have the money, but if people aren’t supporting you because they don’t feel that sense of culture, that sense of community, that sense of — you know — this is something good for the world and it’s just capitalism, then it’s not going to last long.”

To view the full press release, visit https://cnw.fm/feYlH

About Jaxx Cannabis

Jack of all trades, female empowerer, and owner of a San Diego local cannabis retailer, JM Balbuena, got her start in the industry not long after Proposition 64 passed. In a newer fashion, JM opened her wellness brand and dispensary, Jaxx Cannabis, as a medical operation. Operating in one of the most conservative and regulated counties of California, JM waited her turn and played by the rules, allowing Jaxx Cannabis to start running and stay within its communities—unlike some competitors. JM attributes much of her success in keeping the business running to patience and working for the system instead of against it. To stay up-to-date on the expansion of Jaxx Cannabis, follow @jaxx.sandiego and @_jmbalbuena on Instagram.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Participate in Virtual Investor Events Next Week

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represented at two upcoming investor events. The company announced that members of its executive team will be participating in the Tribe Public Webinar, slated for May 31, 2023, and the Investor Summit, scheduled for June 1, 2023. According to the announcement, InMed CEO Eric A. Adams and BayMedica VP of sales and marketing Jerry Griffin will cohost a presentation for the Tribe Public Webinar. The virtual presentation, titled “Addressing the Increasing Demand for Rare Cannabinoids,” will begin at 12 p.m. ET and will include time for questions and answers. At the Investor Summit, Adams will present a corporate overview followed by a Q&A session; his presentation is scheduled to begin at 11:30 a.m. ET. Both presentations will be available on the company’s website following the conclusion of the events.

To view the Tribe Public Webinar presentation, visit https://cnw.fm/3fSqq

To view the Investor Summit presentation, visit https://cnw.fm/X6TGn

To view the full press release, visit https://cnw.fm/jliPr

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — AMA Study Says Medical Cannabis Causes Sustained, Significant Health Improvements

A recent study conducted by the AMA has revealed a significant relationship between the utilization of medical cannabis and notable enhancements in the quality of life experienced by individuals grappling with conditions like insomnia and chronic pain. In a comprehensive retrospective analysis, the researchers examined a sample of 3,148 individuals from Australia that had been prescribed medical cannabis to alleviate symptoms associated with various qualifying diseases.

The study found that cannabis appeared to be beneficial for all eight well-being indicators that were examined, with negative side effects that were infrequently severe.

Throughout their treatment, patients were tasked with assessing their overall well-being across eight distinct categories using a scale ranging from 0 to 100. These categories included bodily pain, general health, physical functioning, mental health, physical role restrictions, emotional role restrictions, vitality and social functioning.

The survey was administered to patients at approximately 45-day intervals, resulting in a total of 15 check-ups. The study discovered that those who used marijuana reported an average benefit range of 6.5 to 18.30 points on a scale of 100. Among the medical conditions for which cannabis has been prescribed, the ones that stood out were chronic pain, accounting for a substantial 68.6% of cases; pain resulting from cancer treatment at 6.0%; insomnia, with a prevalence of 4.8%; and anxiety disorders, accounting for 4.2% of cases.

Patients used a wide range of marijuana products with different cannabinoid compositions, dosages and intake techniques. Even so, there was little difference between the final effects. The researchers also noted a limitation in the study’s retrospective analytic technique, which resulted in a lack of control, making extrapolating the findings more difficult.

This study is only one of many recent research projects showcasing the medicinal advantages of marijuana, reflecting the growing global trend of countries revising their cannabis regulations. For instance, another AMA study revealed that patients with chronic pain who used medical marijuana for more than a month experienced a considerable drop in the amount of opioids they were prescribed.

Last year, the AMA released studies that revealed a significant correlation between the legalization of cannabis in certain states and a reduction in opioid prescriptions among specific cancer patients. Moreover, numerous other studies have consistently demonstrated a connection between the legalization of marijuana and a decline in opioid prescription rates as well as a decrease in the number of overdose fatalities.

Chronic pain comes out prominently as one of the conditions for which patients report benefiting from medical marijuana. It may come as no surprise that enterprises such as IGC Pharma Inc. (NYSE American: IGC) are seeking to develop FDA-approved formulations from cannabis to treat chronic pain and other symptoms.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Michigan Officials Consider Scrapping Pre-Employment Cannabis Testing

Officials in the state of Michigan are considering putting an end to drug testing for cannabis for job applicants of certain government positions. Last week, the state’s Civil Service Commission put forward some amendments to the government’s code of employment on Friday and opened a public comment period on the pair of policies.

This comes after the country’s largest union that represents federal employees adopted an initiative in support of cannabis legalization in 2022, and demanded that policies which penalized federal workers who use marijuana responsibly while they’re off the clock in legal states be repealed.

Commentary from the public may be emailed to MCSC-OGC@mi.gov and has to be submitted to the commission no later than June 23rd.

The first amendment will change the current code, which states that agencies must test applicants for marijuana and other substances. The code will be amended to highlight that drug testing will not be required for new hires who are to fill positions that aren’t test-designated. The current regulations also ban individuals who test positive for marijuana during the application process from applying to other state agencies, in addition to revoking their conditional offers.

Under the new regulation, individuals who currently have active sanctions based on a positive result for cannabis from a test done during the application process for nontest‐designated positions may request that their sanctions be rescinded.

The state of Michigan legalized the medical use of cannabis in 2008 and the recreational use of the drug a decade later.

This isn’t the only state looking into drug testing policies either. Last week, Governor Jay Inslee of Washington state signed a measure into law that protects workers from being discriminated against during the hiring process over their legal use of cannabis. Washington joins Nevada, which has also prohibited employment discrimination for testing positive for cannabis. Other states, including New York and California, offer broader employment protections for adults who lawfully use marijuana away from work and during their off-hours.

Some agencies are also following suit, with the Bureau of Alcohol, Tobacco, Firearms and Explosives recently updating its employment policy.

The updates make it so that applicants who have sold, manufactured or cultivated cannabis in compliance with state laws will not be automatically disqualified during the hiring process. However, those who engaged in these activities while violating state marijuana policies will not be considered.

Additionally, the Secret Service recently loosened restrictions on the previous use of cannabis by prospective agents.

Ending pre-employment cannabis testing could go a long way in getting people to feel freer to use marijuana for medical or recreational purposes. That, in turn, may boost demand for marijuana, thereby triggering a cascading wave of opportunities for even ancillary enterprises such as Advanced Container Technologies Inc. (OTC: ACTX) whose focus is on availing the supplies, such as indoor cultivation equipment, which marijuana companies need to thrive.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.